158 related articles for article (PubMed ID: 22125086)
1. The defective splicing caused by the ISCU intron mutation in patients with myopathy with lactic acidosis is repressed by PTBP1 but can be derepressed by IGF2BP1.
Nordin A; Larsson E; Holmberg M
Hum Mutat; 2012 Mar; 33(3):467-70. PubMed ID: 22125086
[TBL] [Abstract][Full Text] [Related]
2. PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis.
Rawcliffe DFR; Österman L; Nordin A; Holmberg M
Mol Genet Genomic Med; 2018 Nov; 6(6):887-897. PubMed ID: 30209894
[TBL] [Abstract][Full Text] [Related]
3. Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect.
Olsson A; Lind L; Thornell LE; Holmberg M
Hum Mol Genet; 2008 Jun; 17(11):1666-72. PubMed ID: 18296749
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific splicing of ISCU results in a skeletal muscle phenotype in myopathy with lactic acidosis, while complete loss of ISCU results in early embryonic death in mice.
Nordin A; Larsson E; Thornell LE; Holmberg M
Hum Genet; 2011 Apr; 129(4):371-8. PubMed ID: 21165651
[TBL] [Abstract][Full Text] [Related]
5. The High Level of Aberrant Splicing of ISCU in Slow-Twitch Muscle May Involve the Splicing Factor SRSF3.
Rawcliffe DF; Österman L; Lindsten H; Holmberg M
PLoS One; 2016; 11(10):e0165453. PubMed ID: 27783661
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotide corrects splice abnormality in hereditary myopathy with lactic acidosis.
Sanaker PS; Toompuu M; McClorey G; Bindoff LA
Gene; 2012 Feb; 494(2):231-6. PubMed ID: 22155317
[TBL] [Abstract][Full Text] [Related]
7. Transient restoration of succinate dehydrogenase activity after rhabdomyolysis in iron-sulphur cluster deficiency myopathy.
Kollberg G; Melberg A; Holme E; Oldfors A
Neuromuscul Disord; 2011 Feb; 21(2):115-20. PubMed ID: 21196119
[TBL] [Abstract][Full Text] [Related]
8. The SR protein SC35 is responsible for aberrant splicing of the E1alpha pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis.
Gabut M; Miné M; Marsac C; Brivet M; Tazi J; Soret J
Mol Cell Biol; 2005 Apr; 25(8):3286-94. PubMed ID: 15798212
[TBL] [Abstract][Full Text] [Related]
9. Matrin3 binds directly to intronic pyrimidine-rich sequences and controls alternative splicing.
Uemura Y; Oshima T; Yamamoto M; Reyes CJ; Costa Cruz PH; Shibuya T; Kawahara Y
Genes Cells; 2017 Sep; 22(9):785-798. PubMed ID: 28695676
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestation and a new ISCU mutation in iron-sulphur cluster deficiency myopathy.
Kollberg G; Tulinius M; Melberg A; Darin N; Andersen O; Holmgren D; Oldfors A; Holme E
Brain; 2009 Aug; 132(Pt 8):2170-9. PubMed ID: 19567699
[TBL] [Abstract][Full Text] [Related]
11. Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy.
Sanaker PS; Toompuu M; Hogan VE; He L; Tzoulis C; Chrzanowska-Lightowlers ZM; Taylor RW; Bindoff LA
Biochim Biophys Acta; 2010 Jun; 1802(6):539-44. PubMed ID: 20206689
[TBL] [Abstract][Full Text] [Related]
12. Intronic Determinants Coordinate Charme lncRNA Nuclear Activity through the Interaction with MATR3 and PTBP1.
Desideri F; Cipriano A; Petrezselyova S; Buonaiuto G; Santini T; Kasparek P; Prochazka J; Janson G; Paiardini A; Calicchio A; Colantoni A; Sedlacek R; Bozzoni I; Ballarino M
Cell Rep; 2020 Dec; 33(12):108548. PubMed ID: 33357424
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide therapeutics for iron-sulphur cluster deficiency myopathy.
Kollberg G; Holme E
Neuromuscul Disord; 2009 Dec; 19(12):833-6. PubMed ID: 19846308
[TBL] [Abstract][Full Text] [Related]
14. Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines.
Holmes-Hampton GP; Crooks DR; Haller RG; Guo S; Freier SM; Monia BP; Rouault TA
Hum Mol Genet; 2016 Dec; 25(23):5178-5187. PubMed ID: 28007899
[TBL] [Abstract][Full Text] [Related]
15. RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3.
Lorenzi P; Sangalli A; Fochi S; Dal Molin A; Malerba G; Zipeto D; Romanelli MG
Int J Biochem Cell Biol; 2019 Jan; 106():74-83. PubMed ID: 30468920
[TBL] [Abstract][Full Text] [Related]
16. Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5' splice site selection.
Bielli P; Bordi M; Di Biasio V; Sette C
Nucleic Acids Res; 2014 Oct; 42(19):12070-81. PubMed ID: 25294838
[TBL] [Abstract][Full Text] [Related]
17. An intronic element contributes to splicing repression in spinal muscular atrophy.
Kashima T; Rao N; Manley JL
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3426-31. PubMed ID: 17307868
[TBL] [Abstract][Full Text] [Related]
18. A mechanism underlying position-specific regulation of alternative splicing.
Hamid FM; Makeyev EV
Nucleic Acids Res; 2017 Dec; 45(21):12455-12468. PubMed ID: 30053257
[TBL] [Abstract][Full Text] [Related]
19. Large-scale remodeling of a repressed exon ribonucleoprotein to an exon definition complex active for splicing.
Wongpalee SP; Vashisht A; Sharma S; Chui D; Wohlschlegel JA; Black DL
Elife; 2016 Nov; 5():. PubMed ID: 27882870
[TBL] [Abstract][Full Text] [Related]
20. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
Ashiya M; Grabowski PJ
RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
